Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma-Lyte 148 versus Hartmann's solution as cardiopulmonary bypass prime
ACTRN12612000022864Phase 4Completed
- Sponsor
- Austin Hospital
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in metabolic acidosis comparing Plasma-Lyte 148 prime with Hartmann's solution prime (2 arms). Primary endpoint: Standard base deficit. Started Feb 2012; status: completed.
02
Drugs
plasma-lytelactated ringer's solution
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on ACTRN12612000022864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000022864.